'Ketamine Queen' Sentenced to 15 Years for Supplying Drugs to Matthew Perry

‘Ketamine Queen’ Sentenced to 15 Years for Supplying Drugs to Matthew Perry pro-government Pro-government coverage depicts Jasmin Sangha as the central, predatory dealer whose illicit ketamine network led directly to Matthew Perry’s death, and presents the 15-year prison sentence as a morally satisfying and necessary act of justice. These outlets highlight the case as proof that existing laws and institutions, when fully applied, can hold high-end drug suppliers accountable and protect the public. @Telegraf @Alo! @Republika Jasmin (also reported as Jeswen) Sangha, widely referred to in coverage as the “Ketamine Queen,” has been sentenced in federal court to 15 years in prison for supplying the ketamine that contributed to the 2023 overdose death of actor Matthew Perry. Both opposition and pro-government outlets report that Sangha admitted to distributing ketamine resulting in death, that she operated an illicit ketamine supply network catering to high-end or elite clients, and that she also supplied drugs to at least one other man who died of an overdose, making her one of five people charged in connection with the broader case. They similarly note that prosecutors had pushed for a stiff sentence, that Sangha’s plea agreement included an acknowledgment of her role in Perry’s death, and that she is expected to receive the harshest penalty among the defendants, which include doctors and Perry’s personal assistant who have already pleaded guilty to various related offenses.

Coverage across both camps also agrees that Perry had been undergoing ketamine therapy for depression through legitimate medical channels before his death but had turned to illegal sources for larger or more frequent doses in the weeks leading up to his fatal overdose. Outlets from both sides place the case within a broader pattern of celebrity drug misuse and the dangers of powerful anesthetics like ketamine being diverted from medical use to recreational or self-medication markets, highlighting institutional failures in monitoring prescriptions, controlling supply chains, and policing high-end drug networks. There is shared emphasis on how the case exposes gaps in oversight of so-called “therapy” clinics, the complicity of certain licensed professionals, and the challenge for regulators and law enforcement in balancing access to emerging mental health treatments with the need to prevent abuse and trafficking.

Areas of disagreement

Responsibility and blame. Opposition-aligned coverage tends to diffuse responsibility by stressing systemic failures in drug regulation, celebrity culture, and medical oversight, portraying Sangha as a key but not singular link in a chain of negligence that includes doctors, enablers, and Perry’s own risky choices. Pro-government outlets, by contrast, center their narrative on Sangha as the primary villain, repeatedly invoking the “Ketamine Queen” label and framing the 15-year sentence as a just moral reckoning that delivers accountability for Perry’s death.

Role of the state and institutions. Opposition sources generally treat the case as evidence of state underperformance, arguing that law enforcement and regulatory bodies were either asleep at the wheel or overly focused on headline prosecutions rather than prevention and treatment. Pro-government coverage instead underscores the eventual investigation and successful prosecution as proof that institutions work when given time, highlighting the coordination between federal prosecutors, drug enforcement agencies, and the courts as a sign of effective governance.

Framing of Perry and drug use. Opposition reporting more often humanizes Perry as someone struggling with addiction and mental health, cautioning against a simplistic narrative that blames only dealers and warning that criminalization alone cannot solve the issues underlying celebrity drug abuse. Pro-government outlets more readily frame Perry as a victim of a predatory drug network, focusing on Sangha’s alleged targeting of wealthy clients and using moralistic language about “karma” and punishment, with less emphasis on structural addiction treatment failures.

Policy implications and reform. Opposition-leaning coverage tends to use the case as a springboard to call for tighter controls on ketamine clinics, more robust prescription monitoring, and expanded mental health and addiction services, suggesting the sentence alone will not prevent similar tragedies. Pro-government media are more likely to treat the harsh penalty as a deterrent example and to argue that rigorous enforcement of existing drug laws, rather than sweeping reform, is the primary lesson, framing the outcome as a victory for public safety rather than a prompt for systemic change.

In summary, opposition coverage tends to situate Sangha’s conviction within a web of institutional and cultural failures and to question whether punishment without reform will prevent similar deaths, while pro-government coverage tends to emphasize her personal culpability, celebrate the 15-year sentence as proof that the system works, and downplay broader critiques of state and regulatory performance. Story coverage